Abstract
Omadacycline (OMC) showed better in vitro potency than daptomycin (DAP) or vancomycin (VAN) against Van r, Amp r, DAP-nonsusceptible, linezolid-resistant, cfr(B) + Enterococcus faecium strains. In a mouse peritonitis model, OMC also showed significantly better animal survival during the study and at its end than DAP or VAN with these E. faecium strains. However, OMC, DAP, and VAN showed comparable in vitro and in vivo efficacies against a non-vancomycin-resistant, tetracycline-resistant, DAP-susceptible E. faecium strain.
| Original language | English (US) |
|---|---|
| Article number | 00709 |
| Pages (from-to) | e0070921 |
| Journal | Antimicrobial Agents and Chemotherapy |
| Volume | 65 |
| Issue number | 9 |
| DOIs | |
| State | Published - Aug 17 2021 |
Keywords
- E. faecium
- Mouse peritonitis
- Omadacycline
- Microbial Sensitivity Tests
- Enterococcus faecium
- Animals
- Tetracyclines/pharmacology
- Peritonitis/drug therapy
- Mice
- Gram-Positive Bacterial Infections/drug therapy
- Anti-Bacterial Agents/pharmacology
ASJC Scopus subject areas
- Pharmacology (medical)
- Infectious Diseases
- Pharmacology
Divisions
- Infectious Disease
Fingerprint
Dive into the research topics of 'Efficacy of omadacycline against multidrug-resistant enterococcus faecium Strains in a Mouse Peritonitis Model'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS